ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
캐리어 스크리닝 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 연평균 성장률(CAGR) 16.2%로 성장하여 2029년에는 57억 6천만 달러 규모에 이를 전망입니다. 예측기간의 성장은 정밀의료 진보, 패널 제공 확대, 소비자 유전체학와 소비자 직접 검사, 희소 및 초희소질환에 대한 주력, 정부와 보험에 의한 지원, 약리 유전체학의 통합 등에 기인할 수 있습니다. 예측기간의 주요 동향에는 유전자기술의 진보, 출생전검사와의 통합, 개별화의료의 대두, 상담과 교육서비스, 윤리적 및 법적 고찰 등이 포함됩니다.
태아의 염색체 이상과 유전성 질환 증가가 예상되어 캐리어 스크리닝 시장의 성장을 견인합니다. 태아 염색체 이상은 염색체 내의 DNA 수와 양에 이상이 있으며 태아에 영향을 미칩니다. 염색체 이상의 출생 전 검사는 그러한 장애가있는 태아의 위험을 평가하는 데 중요한 역할을합니다. 2022년 2월 세계보건기구(WHO)의 추계에 따르면, 선천성 이상으로 연간 24만명의 신생아가 생후 28일 이내에 사망하고, 또한 생후 1개월부터 5세까지의 어린이 사이에서 17만명이 사망하고 있습니다. 게다가 유엔 정부의 2022년 3월 기사에서는 다운증후군이 전 세계적으로 1,000명에서 1,100명당 1명꼴로 발병하여 연간 3,000-5,000명의 출생아에게 영향을 미치는 것으로 나타났습니다. 이러한 태아의 염색체 이상이나 유전성 질환의 급증은 캐리어 스크리닝 시장의 성장을 가속하는 중요한 요인입니다.
노인 인구 증가는 캐리어 스크리닝 시장의 미래 성장을 가속할 것으로 예상됩니다. 노인 인구는 노인 또는 그 이상의 연령의 개인을 의미합니다. 노인, 특히 늦은 결혼이나 후년에 부모가 될 것을 생각하는 사람들은 유전 위험을 평가하기 위해 임신 전 또는 임신 전 치료의 일환으로 캐리어 스크리닝을 선택할 수 있습니다. 예를 들어, 2024년 10월 스위스에 본부를 두고 있는 정부간 기관인 세계보건기구(WHO)는 2030년까지 세계 6명 중 1명이 60세 이상이 될 것이라고 지적했습니다. 2050년에는 60세 이상의 세계 인구가 두 배로 늘어나 21억 명에 달할 것으로 예상됩니다. 또한 80세 이상의 인구는 2020년부터 2050년까지 3배로 늘어나 4억 2,600만 명에 달할 것으로 예상됩니다. 인구의 고령화율은 이전에 비해 가속화 되고 있습니다. 따라서 노인 인구 증가는 캐리어 스크리닝 시장의 성장을 가속하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 캐리어 스크리닝 시장의 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
최종 이용 산업의 분석
세계 캐리어 스크리닝 시장 : 성장률 분석
세계의 캐리어 스크리닝 시장 실적 : 규모와 성장, 2019-2024년
세계의 캐리어 스크리닝 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계 경력 선별 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 캐리어 스크리닝 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
확장 캐리어 스크리닝
대상 질환 캐리어 스크리닝
세계의 캐리어 스크리닝 시장 : 병상별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
폐질환
혈액 질환
신경질환
기타
세계의 캐리어 스크리닝 시장 : 기술별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
DNA 서열 분석
중합효소 연쇄반응
마이크로어레이
기타
세계의 캐리어 스크리닝 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원
레퍼런스 랩
진료소 및 클리닉
기타
세계의 캐리어 스크리닝 시장 : 확장 캐리어 스크리닝의 서브 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
전체 엑솜 시퀀싱(WES)
차세대 시퀀싱(NGS) 패널
종합적 캐리어 스크리닝 테스트
세계의 캐리어 스크리닝 시장 : 대상 질환 캐리어 스크리닝의 서브 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
단일 유전자 검사
질병 특이적 패널
민족 또는 집단 특이적 스크리닝 검사
제7장 지역별·국가별 분석
세계의 캐리어 스크리닝 시장 :지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 캐리어 스크리닝 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
캐리어 스크리닝 시장 : 경쟁 구도
캐리어 스크리닝 시장 : 기업 프로파일
Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis
BGI Genomics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
Centogene NV Overview, Products and Services, Strategy and Financial Analysis
Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
Fulgent Genetics Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
Genealogy by Genetics Ltd.
Illumina Inc.
Laboratory Corporation of America Holdings
Luminex Corporation
MedGenome Inc.
Myriad Genetics Inc.
Natera Inc.
OPKO Health Inc.
Otogenetics Corporation
Quest Diagnostics Inc.
Sema4 Holdings Corporation
Thermo Fisher Scientific Inc.
23andMe Holding Co.
REALM IDx Inc.
Associated Regional and University Pathologists Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
캐리어 스크리닝 시장 2029년: 새로운 기회를 제공하는 국가
캐리어 스크리닝 시장 2029년: 새로운 기회를 제공하는 부문
캐리어 스크리닝 시장 2029년: 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Carrier screening is a genetic testing method designed to identify the presence of genes associated with specific genetic illnesses. This screening helps determine if individuals carry a gene mutation that, when present in two copies, can lead to hereditary diseases.
Two primary types of carrier screening are utilized such as expanded carrier screening and targeted disease carrier screening. Expanded carrier screening offers assessment for multiple autosomal and X-linked recessive disorders, leveraging advanced genetic testing technologies. This approach allows testing for individuals regardless of their ancestry or geographic origin. The products and services associated with carrier screening fall into the categories of service and product. The medical conditions covered include pulmonary conditions, hematological conditions, neurological conditions, and other relevant medical conditions. The technologies involved in carrier screening encompass DNA sequencing, polymerase chain reaction, microarrays, and various other technologies. Carrier screening services are utilized by a range of end users, including hospitals, reference laboratories, physician offices and clinics, and other entities involved in healthcare and genetic testing.
The carrier screening market research report is one of a series of new reports from The Business Research Company that provides carrier screening market statistics, including carrier screening industry global market size, regional shares, competitors with a carrier screening market share, detailed carrier screening market segments, market trends and opportunities, and any further data you may need to thrive in the carrier screening industry. This carrier screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The carrier screening market size has grown rapidly in recent years. It will grow from $2.72 billion in 2024 to $3.17 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to increasing genetic disorders awareness, rising maternal age, family planning and pregnancy awareness, prevention of genetic diseases, public health initiatives, increased focus on inherited conditions.
The carrier screening market size is expected to see rapid growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to precision medicine advancements, expanded panel offerings, consumer genomics and direct-to-consumer testing, focus on rare and ultra-rare diseases, government and insurance support, pharmacogenomics integration. Major trends in the forecast period include advancements in genetic technologies, integration with prenatal testing, rise in personalized medicine, counseling and education services, ethical and legal considerations.
The anticipated increase in fetal chromosomal abnormalities and genetic disorders is set to drive the growth of the carrier screening market. Fetal chromosomal abnormalities involve deviations in the number or quantity of DNA within a chromosome, impacting a fetus. Prenatal testing for chromosomal abnormalities plays a crucial role in assessing the risk of carrying a fetus with such disorders. According to estimates from the World Health Organization in February 2022, birth defects contribute to the demise of 240,000 newborns in the first 28 days annually, with an additional 170,000 deaths among children aged 1 month to 5 years. Additionally, an article by the United Nations Government in March 2022 highlights that Down syndrome affects 1 in 1,000 to 1 in 1,100 live births globally, resulting in 3,000 to 5,000 annual births. This surge in fetal chromosomal abnormalities and genetic disorders is a significant driver for the growth of the carrier screening market.
The growing geriatric population is projected to enhance the growth of the carrier screening market in the future. The geriatric population refers to individuals who are elderly or older in age. Older adults, particularly those considering parenthood later in life, may choose carrier screening as part of their prenatal or preconception care to assess the genetic risks linked to advanced parental age. For instance, in October 2024, the World Health Organization, a Switzerland-based intergovernmental organization, indicated that by 2030, 1 in 6 people globally will be aged 60 years or older. By 2050, the global population of individuals aged 60 and above is expected to double, reaching 2.1 billion. Additionally, the number of people aged 80 and older is anticipated to triple from 2020 to 2050, reaching 426 million. The rate of population aging is accelerating compared to previous years. Therefore, the rising geriatric population is propelling growth in the carrier screening market.
Major companies in the carrier screening market are concentrating on product developments, such as screening tests family, to maintain their market positions. Screening tests, aimed at asymptomatic individuals, are crucial in identifying risks associated with various conditions, including those related to pregnancy, family planning, and overall health. For example, Blueprint Genetics, a Finland-based genetic testing and diagnostics company, introduced the Screening Tests family in June 2023. This offering aims to provide actionable information for proactive decision-making related to family planning and health, supporting individuals in making informed choices about their well-being.
In the carrier screening market, major companies are also focusing on product developments, such as carrier screening panels, to sustain their market positions. Carrier screening panels involve genetic tests to identify individuals carrying gene mutations for specific conditions, even without exhibiting symptoms. In February 2023, Fulgent Genetics, Inc., a US-based genetic testing and diagnostics company, launched the Beacon787 expanded carrier screening panel. This comprehensive panel covers 787 genes associated with autosomal recessive and X-linked conditions, aligning with guidelines advocating for comprehensive screening for all pregnant and planning individuals. Fulgent's Beacon787 aims to provide equitable and pan-ethnic screening, emphasizing its commitment to advancing genetic testing and promoting informed family planning decisions.
In a strategic move, Sema4 OpCo Inc., a US-based provider of patient-focused health intelligence, acquired GeneDx LLC for $623 million in May 2022. This acquisition positions Sema4 as a prominent genomic testing company in the United States, enhancing its health information database and contributing to improved patient care and therapeutic research. GeneDx LLC, a US-based company specializing in the analysis of rare disorders and genomic testing, becomes an integral part of Sema4's commitment to advancing genomic insights in healthcare.
Major companies operating in the carrier screening market are Invitae Corporation, BGI Genomics Co. Ltd., Centogene NV, Eurofins Scientific SE, Fulgent Genetics Inc., Genealogy by Genetics Ltd., Illumina Inc., Laboratory Corporation of America Holdings, Luminex Corporation, MedGenome Inc., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 Holdings Corporation, Thermo Fisher Scientific Inc., 23andMe Holding Co., REALM IDx Inc., Associated Regional and University Pathologists Inc., Genedx LLC, Genomic Health Inc., GenPath Consultants And Technologies Private Limited, Good Start Genetics Inc., NIPD Genetics Co. Pvt. Ltd., OraSure Technologies Inc., Pathway Genomics Corp., PerkinElmer Inc., PreventionGenetics LLC, Progenity Inc.
North America was the largest region in the carrier screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the carrier screening market report during the forecast period. The regions covered in the carrier screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the carrier screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The carrier screening market includes revenues earned by entities by providing customized panel testing and predesigned panel testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Carrier Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on carrier screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for carrier screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The carrier screening market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Carrier Screening Market Characteristics
3. Carrier Screening Market Trends And Strategies
4. Carrier Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Carrier Screening Growth Analysis And Strategic Analysis Framework
5.1. Global Carrier Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Carrier Screening Market Growth Rate Analysis
5.4. Global Carrier Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Carrier Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Carrier Screening Total Addressable Market (TAM)
6. Carrier Screening Market Segmentation
6.1. Global Carrier Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Expanded Carrier Screening
Targeted Disease Carrier Screening
6.2. Global Carrier Screening Market, Segmentation By Medical Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pulmonary Conditions
Hematological Conditions
Neurological Conditions
Other Medical Conditions
6.3. Global Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
DNA Sequencing
Polymerase Chain Reaction
Microarrays
Other Technologies
6.4. Global Carrier Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Reference Laboratories
Physician Offices And Clinics
Other End Users
6.5. Global Carrier Screening Market, Sub-Segmentation Of Expanded Carrier Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Whole Exome Sequencing (WES)
Next-Generation Sequencing (NGS) Panels
Comprehensive Carrier Screening Tests
6.6. Global Carrier Screening Market, Sub-Segmentation Of Targeted Disease Carrier Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Gene Tests
Disease-Specific Panels
Ethnic Or Population-Specific Screening Tests
7. Carrier Screening Market Regional And Country Analysis
7.1. Global Carrier Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Carrier Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
